Publications of A Henning

Talk (60)

321.
Talk
Scheidegger, M.; Fuchs A, Lehmann M, Grimm S, Boeker H, Seifritz, E.; Henning, A.: Effect of an antidepressant dose of Ketamine on prefrontal aspartate, glutamine and GABA levels in healthy subjects: assessing the post-infusion interval with 1H MRS. 21st Annual Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine (ISMRM 2013), Salt Lake City, UT, USA (2013)
322.
Talk
Henning, A.: Ultra-high field human MRI and MRS. Danish Research Centre for Magnetic Resonance (DRCMR), Copenhagen, Denmark (2013)
323.
Talk
Henning, A.: High Resolution 1H MRS Imaging. ISMRM Scientific Workshop on Ultra High Field MRI: What is in Full Bloom & What is Sprouting?, Noordwijk aan Zee, The Netherlands (2013)
324.
Talk
Henning, A.: In vivo MR spectroscopy at high and ultra-high field strength. MRI Seminar: University of Texas South West, Dallas, TX, USA (2012)
325.
Talk
Henning, A.: MultiTX and Dynamic B0 Shim Updating. Philips Medical Systems: 7T User Meeting, Columbus, OH, USA (2012)
326.
Talk
Scheidegger, M.; Walter, M.; Lehmann, M.; Metzger, C.; Grimm, S.; Boeker, H.; Boesiger, P.; Henning, A.; Seifritz, E.: Ketamine decreases resting state functional connectivity between networks via the dorsal nexus: implications for major depression. Third Biennial Conference on Resting State Brain Connectivity, Magdeburg, Germany (2012)
327.
Talk
Henning, A.: In vivo MR spectroscopy at high and ultra-high field strength. Research Seminar GE Global Research, München, Germany (2012)
328.
Talk
Henning, A.: In vivo MR spectroscopy at high and ultra-high field strength. Maastricht University, Maastricht, The Netherlands (2012)
329.
Talk
Henning, A.: In vivo MR spectroscopy at high and ultra-high field strength. Cardiology Seminar: University of Aberdeen, Aberdeen, UK (2012)
330.
Talk
Henning, A.: In vivo NMR spectroscopy at ultra-high field: chances and challenges. XIXth Swiss NMR Symposium 2012 , Bern, Switzerland (2012)
331.
Talk
Henning, A.: In vivo MR spectroscopy at high and ultra-high field strength. Research Seminar: Max-Planck-Institut für Biologische Kybernetik, Tübingen, Germany (2011)
332.
Talk
Henning, A.: In vivo MRS at high and ultra-high fields. CIBM HUG Seminar: University of Geneva, Geneva, Switzerland (2010)
333.
Talk
Henning, A.: Ongoing spectroscopy projects, Philips Medical Systems. Philips Medical Systems: 7T User Meeting, Noordwijk, The Netherlands (2010)
334.
Talk
Henning, A.: Advances in MR spectroscopy at higher fields and applications of glutamatergic and GABAergic imaging in neurological and psychiatric diseases. SFB 779 Colloquium: Otto-von-Guericke-Universität, Magdeburg, Germany (2009)
335.
Talk
Henning, A.: MRS and MRI at high and ultra-high field. 7T User Group Colloquium: Vanderbuilt University, Nashville, TN, USA (2009)
336.
Talk
Henning, A.: MRS and MRI at high and ultra-high field. Radiology Colloquium: UCLA, Los Angeles, CA, USA (2009)
337.
Talk
Henning, A.: Recent advances in quantitative MRS. AAPM 51st Annual Meeting, Anaheim, CA, USA (2009)
338.
Talk
Henning, A.: Towards quantitative MRS at 7T. 7T Philips User Meeting, Dallas, TX, USA (2009)
339.
Talk
Henning, A.: In vivo MRS at high and ultra-high field strength. AMSM Colloquium: Universität Bern, Bern, Switzerland (2008)
340.
Talk
Henning, A.: 1H MRS / MRSI Concepts for 7T. 4th Philips 7T User Meeting, Ittingen, Switzerland (2008)
Go to Editor View